{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-047977","form_type":"8-K","ticker":"MRK","cik":"0000310158","company_name":"Merck & Co., Inc.","filed_at":"2022-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.162601+00:00","generated_at":"2026-06-26T05:51:57.764224+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Merck ends exclusion of upfront/milestone payments and pre-approval asset charges from non-GAAP results","bullets":["Merck will no longer exclude upfront/milestone payments and pre-approval asset acquisition charges from non-GAAP results, effective Q1 2022.","Recast FY2021 non-GAAP EPS from continuing ops is $5.37, down from previously reported $6.02; FY2020 revised to $2.97 from $4.53.","Change aligns with SEC staff views; does not affect Q1 2021 or Q1 2022 non-GAAP results.","Revised non-GAAP R&D expense for full-year 2021 is $11,738M vs previously reported $10,077M (increase of $1,661M).","The recast 2021 annual net income attributable to Merck is $13,623M vs previously $15,282M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-047977","json":"https://secwatch.observer/filing/0001104659-22-047977.json","markdown":"https://secwatch.observer/filing/0001104659-22-047977.md","text":"https://secwatch.observer/filing/0001104659-22-047977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310158/000110465922047977/0001104659-22-047977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310158/000110465922047977/tm2212593d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:51:57.764224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}